Dyne Therapeutics, Inc.
DYN
25 insider filings · Latest: May 13, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Apr 23, 2026 | Apr 23 8:45 PM | Atlas Venture Associates XI, LP | Proposed Sale | 377 | $19.67 | $7.4K | — | View → |
| Apr 22, 2026 | Apr 23 8:15 PM | Dirk KerstenDirector | Sale | 2,652 | $20.00 | $53.0K | 4,196,573(I) | View → |
| Apr 21, 2026 | Apr 23 8:15 PM | Dirk KerstenDirector | Sale | 8,300 | $20.01 | $166.1K | 4,199,225(I) | View → |
| Apr 22, 2026 | Apr 22 10:27 PM | Jason P RhodesDirector | Sale | 287,956 | $19.68 | $5.7M | 1,285,704(I) | View → |
| Apr 21, 2026 | Apr 22 10:27 PM | Jason P RhodesDirector | Sale | 274,297 | $19.52 | $5.4M | 1,345,367(I) | View → |
| Apr 20, 2026 | Apr 22 10:27 PM | Jason P RhodesDirector | Sale | 272,049 | $20.06 | $5.5M | 1,402,200(I) | View → |
| Apr 22, 2026 | Apr 22 8:54 PM | Atlas Venture Opportunity Fund I, LP | Proposed Sale | 59,663 | $19.21 | $1.1M | — | View → |
| Apr 22, 2026 | Apr 22 8:53 PM | Atlas Venture Opportunity Fund II, LP | Proposed Sale | 75,866 | $19.21 | $1.5M | — | View → |
| Apr 22, 2026 | Apr 22 8:53 PM | Atlas Venture Fund XI, LP | Proposed Sale | 150,942 | $19.21 | $2.9M | — | View → |
| Apr 22, 2026 | Apr 22 8:52 PM | Atlas Venture Associates XI, LP | Proposed Sale | 1,485 | $19.21 | $28.5K | — | View → |
| Apr 21, 2026 | Apr 21 8:54 PM | Atlas Venture Fund XI, LP | Proposed Sale | 143,749 | $20.02 | $2.9M | — | View → |
| Apr 21, 2026 | Apr 21 8:53 PM | Atlas Venture Opportunity Fund I, LP | Proposed Sale | 56,820 | $20.02 | $1.1M | — | View → |
| Apr 21, 2026 | Apr 21 8:53 PM | Atlas Venture Opportunity Fund II, LP | Proposed Sale | 72,315 | $20.02 | $1.4M | — | View → |
| Apr 21, 2026 | Apr 21 8:53 PM | Atlas Venture Associates XI, LP | Proposed Sale | 1,413 | $20.02 | $28.3K | — | View → |
| Apr 20, 2026 | Apr 21 8:15 PM | Dirk KerstenDirector | Sale | 125,274 | $20.07 | $2.5M | 4,207,525(I) | View → |
| Apr 17, 2026 | Apr 21 8:15 PM | Dirk KerstenDirector | Sale | 211,974 | $20.29 | $4.3M | 4,332,799(I) | View → |
| Apr 20, 2026 | Apr 20 8:44 PM | Atlas Venture Fund XI, LP | Proposed Sale | 142,571 | $20.41 | $2.9M | — | View → |
| Apr 20, 2026 | Apr 20 8:44 PM | Atlas Venture Opportunity Fund I, LP | Proposed Sale | 56,355 | $20.41 | $1.2M | — | View → |
| Apr 20, 2026 | Apr 20 8:44 PM | Atlas Venture Opportunity Fund II, LP | Proposed Sale | 71,722 | $20.41 | $1.5M | — | View → |
| Apr 20, 2026 | Apr 20 8:43 PM | Atlas Venture Associates XI, LP | Proposed Sale | 1,401 | $20.41 | $28.6K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Feb 12, 2026 | Feb 17 10:11 PM | John CoxDirector, CEO & President | Grant/Award | 285,000 | $16.00 | 285,000(D) | View → |
| Feb 12, 2026 | Feb 17 10:10 PM | Douglas KerrChief Medical Officer | Grant/Award | 130,000 | $16.00 | 130,000(D) | View → |
| Feb 12, 2026 | Feb 17 10:09 PM | Johanna Friedl-NadererChief Commercial Officer | Grant/Award | 90,000 | $16.00 | 90,000(D) | View → |
| Feb 12, 2026 | Feb 17 10:08 PM | Erick LuceraChief Financial Officer | Grant/Award | 105,000 | $16.00 | 105,000(D) | View → |